Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 4, 2024International Journal of Molecular SciencesOpen Access

Myeloid-Derived Suppressor Cells: Therapeutic Target for Gastrointestinal Cancers

View Full Paper
Ask AI
Bookmark
Share

Authors

JAJunaid ArshadARA. Ramachandra RaoMRMatthew Leonard Repp

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Arshad et al. (2024) studied this question.

synapsesocial.com/papers/68e75c84b6db6435876d3324https://doi.org/10.3390/ijms25052985
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 15-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell–Dependent Antitumor Immunity2010 · 1,239 citations
  2. 2Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs2018 · 227 citations
  3. 3Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells2009 · 765 citations
  4. 4Oxaliplatin-Resistant Hepatocellular Carcinoma Drives Immune Evasion Through PD-L1 Up-Regulation and PMN-Singular Recruitment2022 · 33 citations
  5. 5Histamine Promotes the Development of Monocyte-Derived Dendritic Cells and Reduces Tumor Growth by Targeting the Myeloid NADPH Oxidase2015 · 42 citations